Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 40 years or older, of any gender
- People who have been diagnosed in both eyes with either high eye pressure (ocular hypertension), suspected glaucoma, or mild open-angle glaucoma, as defined by the American Academy of Ophthalmology guidelines
- People who are not currently using any eye pressure-lowering medications, and whose eye pressure in each eye measures between 21 and 35 mmHg, with the two eyes measuring within 3 mmHg of each other
- People with vision of 20/50 or better (with correction if needed)
- People who are able to read and understand the study requirements and sign a written consent form
- People who are willing to follow all study instructions and attend all scheduled check-up appointments over 12 months
Who may not be able to join:
- People where a specific part of the eye (the scleral spur, located in the drainage angle) cannot be clearly seen during a standard eye examination called gonioscopy
- People with certain types of glaucoma other than mild open-angle glaucoma, such as glaucoma present from birth, angle-closure glaucoma, or glaucoma caused by other eye conditions (confirm with trial site for the full list)
- People currently taking any oral or eye-drop medications to lower eye pressure
- People who have had any previous eye surgery, except for cataract surgery performed at least 2 years before joining the trial (YAG capsulotomy is also accepted if performed at least 60 days before joining)
- People with significant eye conditions other than cataracts or glaucoma, such as advanced macular degeneration or proliferative diabetic retinopathy
- People who have had a significant eye infection or inflammation within the 6 months before screening
- People who have had a corneal transplant, or who have a significant corneal condition such as advanced Fuchs' dystrophy
- People whose eye media (the clear parts of the eye) are too cloudy to allow a clear view of internal eye structures
- People with an uncontrolled health condition that the trial doctor considers a risk to their safety or that may prevent them from completing all study visits
- People who have participated in another clinical trial involving a drug or device within the past 30 days
- Women who are pregnant or breastfeeding, or women of childbearing age who are not using a medically accepted form of contraception
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: George R Wandling, MD, Twin Cities Eye Consultants - Partner
Phone: 612-999-2020
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean Decrease in Intraocular Pressure (IOP) from Baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.